procrin mensual 3,75 mg 1 xeringa precargada 1 ml
procrin semestral 30 mg 1 xeringa precargada 1 ml
lutrate depot 3,75 mg 1 vial+1 xeringa precargada
ginecrin depot 3,75 mg 1 vial 2 ml
procrin 1 mg/0,2 ml (14 dosis) 1 vial 2,8 ml
lutrate depot trimestral 22.5 mg 1 vial pols + 1 xeringa disolvent 2 ml
degarelix accord
accord healthcare s.l.u. - degarelix acetate - néoplasmes prostatiques - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
visanne comprimé
bayer inc - diénogest - comprimé - 2mg - diénogest 2mg - progestins
jamp dienogest comprimé
jamp pharma corporation - diénogest - comprimé - 2mg - diénogest 2mg - progestins
firmagon 80 mg poudre et solvant pour la préparation d'une suspension injectable (solvant en seringue préremplie)
ferring ag - degarelixum - poudre et solvant pour la préparation d'une suspension injectable (solvant en seringue préremplie) - praeparatio cryodesiccata: degarelixum 80 mg ut degarelixi acetas 88.2 mg, mannitolum, pro vitro. solvens: aqua ad iniectabile 4.2 ml. - gnrh-bloquants pour le traitement de cancer de la prostate - synthetika